Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herling

Showing results (461-470 of 481) with videos related to

Pageof 49
Sort By:
Genes, Chromosomes & Cancer|November 3, 2019
Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemiaPaurnima Patil, Agata Cieslak, Stephan H Bernhart, et al.
Journal of Medicinal Chemistry|June 8, 2021
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic LeukemiaKrimo Toutah, Nabanita Nawar, Sanna Timonen, et al.
Biomarker Research|October 28, 2020
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemiaCarlos Cuesta-Mateos, Patricia Fuentes, Alexandra Schrader, et al.
Hemasphere|February 20, 2020
Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG)Nadine Kutsch, Jasmin Bahlo, Sandra Robrecht, et al.
Blood|June 28, 2024
Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responsesJana von Jan, Sanna Timonen, Till Braun, et al.
Nature Cancer|April 19, 2024
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myelomaMichael Rade, Nora Grieb, Ronald Weiss, et al.
Hemasphere|December 2, 2024
Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphomaDaniel Pölöske, Helena Sorger, Anna Schönbichler, et al.
Nature Communications|February 22, 2018
Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemiaCarmen D Herling, Nima Abedpour, Jonathan Weiss, et al.
The Journal of Experimental Medicine|April 13, 2016
CD1d-restricted peripheral T cell lymphoma in mice and humansEmmanuel Bachy, Mirjam Urb, Shilpi Chandra, et al.
EMBO Molecular Medicine|July 26, 2021
LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathiesMarc Emmenegger, Elena De Cecco, Marian Hruska-Plochan, et al.
Pageof 49

Showing results (461-470 of 481) with videos related to

Sort By:
Pageof 49
Genes, Chromosomes & Cancer|November 3, 2019
Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemiaPaurnima Patil, Agata Cieslak, Stephan H Bernhart, et al.
Journal of Medicinal Chemistry|June 8, 2021
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic LeukemiaKrimo Toutah, Nabanita Nawar, Sanna Timonen, et al.
Biomarker Research|October 28, 2020
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemiaCarlos Cuesta-Mateos, Patricia Fuentes, Alexandra Schrader, et al.
Hemasphere|February 20, 2020
Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG)Nadine Kutsch, Jasmin Bahlo, Sandra Robrecht, et al.
Blood|June 28, 2024
Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responsesJana von Jan, Sanna Timonen, Till Braun, et al.
Nature Cancer|April 19, 2024
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myelomaMichael Rade, Nora Grieb, Ronald Weiss, et al.
Hemasphere|December 2, 2024
Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphomaDaniel Pölöske, Helena Sorger, Anna Schönbichler, et al.
Nature Communications|February 22, 2018
Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemiaCarmen D Herling, Nima Abedpour, Jonathan Weiss, et al.
The Journal of Experimental Medicine|April 13, 2016
CD1d-restricted peripheral T cell lymphoma in mice and humansEmmanuel Bachy, Mirjam Urb, Shilpi Chandra, et al.
EMBO Molecular Medicine|July 26, 2021
LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathiesMarc Emmenegger, Elena De Cecco, Marian Hruska-Plochan, et al.
Pageof 49